DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

3DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Cirtuvivint [inn], 7t1py32zph, 2143917-62-6, 4-pyridinecarboxamide, 2-(4-methyl-1-piperazinyl)-n-(6-(1-methyl-1h-pyrazol-4-yl)-3-isoquinolinyl)-, Unii-7t1py32zph, Chembl4784318

Molecular Formula

C₂₄H₂₅N₇O

Molecular Weight

427.5 g/mol

InChI Key

BQWWOBKMDWACGC-UHFFFAOYSA-N

FDA UNII

7T1PY32ZPH

1 2D Structure

Cirtuvivint

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-(4-methylpiperazin-1-yl)-N-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]pyridine-4-carboxamide

2.1.2 InChI

InChI=1S/C24H25N7O/c1-29-7-9-31(10-8-29)23-13-18(5-6-25-23)24(32)28-22-12-20-11-17(3-4-19(20)14-26-22)21-15-27-30(2)16-21/h3-6,11-16H,7-10H2,1-2H3,(H,26,28,32)

2.1.3 InChI Key

BQWWOBKMDWACGC-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CN1CCN(CC1)C2=NC=CC(=C2)C(=O)NC3=NC=C4C=CC(=CC4=C3)C5=CN(N=C5)C

2.2 Other Identifiers

2.2.1 UNII

7T1PY32ZPH

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Cirtuvivint [inn]

2. 7t1py32zph

3. 2143917-62-6

4. 4-pyridinecarboxamide, 2-(4-methyl-1-piperazinyl)-n-(6-(1-methyl-1h-pyrazol-4-yl)-3-isoquinolinyl)-

5. Unii-7t1py32zph

6. Chembl4784318

7. Schembl19516414

8. Bdbm293424

9. Ex-a6035

10. Us10106527, Compound 10

11. Nsc835563

12. Us10106527, Compound 142

13. Us10106527, Compound 143

14. Us10106527, Compound 144

15. Us10106527, Compound 459

16. Nsc-835563

17. Sm08502

18. Sm-08502

19. Hy-137435

20. Cs-0138635

21. 2-(4-methylpiperazin-1-yl)-n-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]pyridine-4-carboxamide

2.4 Create Date

2018-01-29

3 Chemical and Physical Properties

Molecular Formula	C₂₄H₂₅N₇O
Molecular Weight	427.5 g/mol
XLogP3	2.4
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	4
Exact Mass	427.21205845 g/mol
Monoisotopic Mass	427.21205845 g/mol
Topological Polar Surface Area	79.2 Å²
Heavy Atom Count	32
Formal Charge	0
Complexity	640
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1